These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Utility of Transjugular Intrahepatic Portosystemic Shunt Placement for Maintaining Portal Vein Patency in Candidates on Wait Lists Who Develop Thrombus. Alani M; Rowley M; Kang P; Chen S; Hirsch K; Seetharam A Exp Clin Transplant; 2020 Dec; 18(7):808-813. PubMed ID: 31830878 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. D'Avola D; Bilbao JI; Zozaya G; Pardo F; Rotellar F; Iñarrairaegui M; Quiroga J; Sangro B; Herrero JI Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469 [TBL] [Abstract][Full Text] [Related]
6. Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis. Matsushima H; Fujiki M; Sasaki K; Cywinski JB; D'Amico G; Uso TD; Aucejo F; David Kwon CH; Eghtesad B; Miller C; Quintini C; Hashimoto K Surgery; 2020 Jul; 168(1):33-39. PubMed ID: 32268937 [TBL] [Abstract][Full Text] [Related]
7. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications. Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789 [TBL] [Abstract][Full Text] [Related]
9. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. Membreno F; Baez AL; Pandula R; Walser E; Lau DT J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494 [TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt as a bridge to liver transplant: Current state and future directions. Sellers CM; Nezami N; Schilsky ML; Kim HS Transplant Rev (Orlando); 2019 Apr; 33(2):64-71. PubMed ID: 30477811 [TBL] [Abstract][Full Text] [Related]
11. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation. King A; Masterton G; Gunson B; Olliff S; Redhead D; Mangat K; Oniscu G; Hayes P; Tripathi D Liver Transpl; 2011 Jul; 17(7):771-8. PubMed ID: 21714062 [TBL] [Abstract][Full Text] [Related]
12. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients. Choi DX; Jain AB; Orloff MS J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787 [TBL] [Abstract][Full Text] [Related]
13. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis. Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660 [TBL] [Abstract][Full Text] [Related]
14. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872 [TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years. ter Borg PC; Hollemans M; Van Buuren HR; Vleggaar FP; Groeneweg M; Hop WC; Laméris JS Radiology; 2004 May; 231(2):537-45. PubMed ID: 15044746 [TBL] [Abstract][Full Text] [Related]